EUROKLEIS SRL

Their core work

Eurokleis is a Rome-based consultancy that provides innovation management, communication, and exploitation services to EU-funded research consortia. Their project portfolio spans wildly different technical domains — from urban transport to 360° media to regenerative medicine — which strongly suggests they contribute horizontal expertise (dissemination, stakeholder engagement, social media strategy, policy analysis) rather than deep domain research. They help research projects translate results into market-ready outputs and connect with end users through living labs, digital storytelling, and innovation ecosystem tools.

What they specialise in

How they've shifted over time

In their early H2020 period (2016-2018), Eurokleis worked on innovation ecosystems, startup policy, living labs, and social media — classic innovation consultancy territory. Their later projects shifted toward technically complex domains: 3D/360° media production (Hyper360) and regenerative medicine with AI and neuromorphic engineering (HERMES). This suggests the company has been expanding from pure innovation support into more technically demanding sectors, potentially building deeper expertise in digital content and health-tech dissemination.

Eurokleis is moving from general innovation consultancy toward supporting advanced biomedical and AI research projects, suggesting they are building credibility in health-tech exploitation and dissemination.

How they like to work

Eurokleis exclusively participates as a partner — they have never coordinated a project, which is typical of service-oriented SMEs that join consortia for specific horizontal tasks. With 44 unique partners across just 4 projects, they work in medium-to-large consortia (averaging 11+ partners per project) and appear to build new relationships each time rather than repeating with the same partners. This makes them a flexible, plug-in contributor rather than a consortium hub.

Eurokleis has collaborated with 44 unique partners across 15 countries through just 4 projects, giving them a broad but shallow European network. Their reach spans well beyond Southern Europe, indicating comfort working in diverse multinational consortia.

What sets them apart

Eurokleis stands out as a versatile Italian SME that can handle dissemination, communication, and innovation management across very different technical domains — from urban transport to regenerative medicine. For consortium builders, their value is precisely this domain-agnostic flexibility: they bring proven methods for public engagement, social media strategy, and exploitation planning without needing deep technical onboarding. Their HERMES involvement shows they can operate credibly even in highly specialized biomedical contexts.

Highlights from their portfolio

• HERMES
  Their largest grant (EUR 245,875) and most technically ambitious project, focused on hybrid regenerative medicine and neuromorphic AI — a significant leap from their earlier innovation consultancy work.
• Hyper360
  Bridges their communication expertise with emerging 3D/360° media technology, showing capacity to work at the intersection of content production and technical innovation.
• I3
  Most representative of their core identity — innovation ecosystems, startup support, and living lab methodologies — revealing what they likely do best.